CDTX
Price
$22.84
Change
-$1.42 (-5.85%)
Updated
Jun 13 closing price
Capitalization
296.23M
VTYX
Price
$2.56
Change
+$0.07 (+2.81%)
Updated
Jun 13 closing price
Capitalization
182.17M
54 days until earnings call
Interact to see
Advertisement

CDTX vs VTYX

Header iconCDTX vs VTYX Comparison
Open Charts CDTX vs VTYXBanner chart's image
Cidara Therapeutics
Price$22.84
Change-$1.42 (-5.85%)
Volume$239.4K
Capitalization296.23M
Ventyx Biosciences
Price$2.56
Change+$0.07 (+2.81%)
Volume$844.13K
Capitalization182.17M
CDTX vs VTYX Comparison Chart
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. VTYX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a StrongBuy and VTYX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (CDTX: $22.84 vs. VTYX: $2.56)
Brand notoriety: CDTX and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 141% vs. VTYX: 56%
Market capitalization -- CDTX: $296.23M vs. VTYX: $182.17M
CDTX [@Biotechnology] is valued at $296.23M. VTYX’s [@Biotechnology] market capitalization is $182.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, VTYX is a better buy in the long-term than CDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 5 TA indicator(s) are bullish while VTYX’s TA Score has 5 bullish TA indicator(s).

  • CDTX’s TA Score: 5 bullish, 5 bearish.
  • VTYX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VTYX is a better buy in the short-term than CDTX.

Price Growth

CDTX (@Biotechnology) experienced а -9.44% price change this week, while VTYX (@Biotechnology) price change was +4.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

CDTX is expected to report earnings on May 08, 2025.

VTYX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($296M) has a higher market cap than VTYX($182M). VTYX YTD gains are higher at: 16.895 vs. CDTX (-15.030). VTYX has higher annual earnings (EBITDA): -135.48M vs. CDTX (-192.6M). VTYX has more cash in the bank: 229M vs. CDTX (168M). CDTX has less debt than VTYX: CDTX (2.67M) vs VTYX (10.5M). CDTX has higher revenues than VTYX: CDTX (302K) vs VTYX (0).
CDTXVTYXCDTX / VTYX
Capitalization296M182M163%
EBITDA-192.6M-135.48M142%
Gain YTD-15.03016.895-89%
P/E RatioN/AN/A-
Revenue302K0-
Total Cash168M229M73%
Total Debt2.67M10.5M25%
FUNDAMENTALS RATINGS
CDTX: Fundamental Ratings
CDTX
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDTXVTYX
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIOPX49.23N/A
N/A
Baron Opportunity Retail
AVALX46.69N/A
N/A
Aegis Value I
SESGX23.52N/A
N/A
Sit ESG Growth S
DMCFX28.34N/A
N/A
Invesco Discovery Mid Cap Growth R5
SJCAX30.71N/A
N/A
Steward Large Cap Core A

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-5.85%
BPTSY - CDTX
92%
Closely correlated
N/A
REPL - CDTX
38%
Loosely correlated
-1.06%
IVVD - CDTX
36%
Loosely correlated
-6.47%
VTYX - CDTX
36%
Loosely correlated
+2.81%
CVAC - CDTX
36%
Loosely correlated
-0.54%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with IMNM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
+2.81%
IMNM - VTYX
48%
Loosely correlated
-6.03%
IPSC - VTYX
48%
Loosely correlated
-4.10%
KYMR - VTYX
46%
Loosely correlated
-0.70%
SYRE - VTYX
46%
Loosely correlated
-2.37%
KOD - VTYX
42%
Loosely correlated
+5.43%
More